Atlas Trials

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

Clinical trial NCT06531629 · COMPLETED

Trial details

NCT number
NCT06531629
Sponsor
Peking University First Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney Cancer
Start date
2000-01-01
Primary completion
2020-12-31
Enrollment
72408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.